Skip to main content
. 2023 Oct 25;21:750. doi: 10.1186/s12967-023-04639-w

Table 3.

Cox proportional hazard ratios (HRs) of the identified cMetS-S trajectory patterns for incidence type 2 diabetes mellitus in normoglycemic and prediabetic individuals

Events IR (95% CI)a HR (95% CI) Test PH p-valueb
Model 1 Model 2 Model 3 Model 4
Normoglycemic subjects at baseline (n = 3260)
Class 1 (n = 867) 15 2.1 (1.2–3.4) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Class 2 (n = 1558) 83 6.1 (4.9–7.6) 2.67 (1.53–4.68) 2.64 (1.51–4.62) 2.39 (1.36–4.21) 2.20 (1.25–3.88) 0.41
Class 3 (n = 835) 159 20.1 (17.2–23.4) 9.46 5.44–16.43) 9.24 (5.31–16.07) 7.93(4.51–13.94) 7.12 (6.05–12.52) 0.78
Prediabetic subjects at baseline (n = 671)
Class 1 (n = 64) 16 15.6 (9.6–25.5) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Class 2 (n = 307) 94 37.8 (30.9–46.3) 2.54 (1.46–4.41) 2.51 (1.45–4.37) 2.60 (1.50–4.52) 2.53 (1.46–4.66) 0.09
Class 3 (n = 300) 105 60.6 (50.1–73.4) 4.04 (2.32–7.03) 3.74 (2.13–6.56) 3.99 (2.27–7.00) 3.78 (2.15–6.65) 0.14

Model 1: Adjusted for age and sex

Model 2: Adjusted for age, sex, education, DM family history

Model 3: Adjusted for age, sex, education, DM family history, physical activity, obesity, antihypertensive drug use, lipid-lowering drug use

Model 4: Adjusted for age, sex, education, DM family history, physical activity, obesity, antihypertensive drug use, lipid-lowering drug use. and fasting plasma glucose

The population was classified into three trajectory classes using latent class analysis, including trajectories of low (class 1), medium (class 2), and high (class 3) cMetS-S

CMetS-S, continuous metabolic syndrome severity score; PH, proportional-hazards assumption

aIR Incidence rate per 1,000 person-years

bThe proportional hazards assumption was tested based on Schoenfeld residuals. There is no evidence that proportional-hazards assumption has been violated (p > 0.5). In the fully adjusted model (model 4), the p-value of the proportional hazards assumption of the global test in normoglycemic and prediabetic subjects at baseline is equal to 0.18 and 0.56, respectively